Quanta Dialysis Technologies and Innovative Renal Care Partnership
Quanta Dialysis Technologies, known for its remarkable Quanta™ Dialysis System, is joining forces with Innovative Renal Care (IRC). This strategic partnership aims to enhance access to innovative dialysis solutions for patients throughout the United States in a multi-year agreement.
Objectives of the Collaboration
The primary goal of this partnership is to broaden the reach of the Quanta Dialysis System within selected IRC programs. This innovative initiative is set to transform the landscape of kidney care, especially for acute care patients who require reliable and efficient dialysis services.
Pilot Program Launch
Earlier this year, IRC commenced a pilot program to assess the Quanta Dialysis System’s adaptability and usability in various care environments, including ICU and bedside settings. Over 130 treatments have already been performed, which includes administering gentle Continuous Renal Replacement Therapy (CRRT) for patients facing hemodynamic instability. This pilot phase demonstrates the Quanta system's flexibility and efficiency in real-world applications.
Following Success with the Pilot
After evaluating the pilot’s outcomes, Quanta and IRC entered into a purchase agreement that encompasses not only the essential capital equipment and disposables but also an option for integrating Electronic Medical Records (EMR) to improve therapy monitoring and operational efficiencies.
Distinct Advantages of Quanta Dialysis System
The Quanta Dialysis System stands out with its diverse range of features:
- It offers a unique prescription flexibility that allows for CRRT, Sustained Low Efficiency Dialysis (SLED), and Intermittent Hemodialysis (IHD) on a single machine.
- Its compact design and user-friendly interface enhance bedside portability, improving usability for healthcare staff.
- Operational benefits are significant, including lower maintenance needs and simplified disinfection processes, resulting in cost savings.
- IRC has the option to train its technicians to manage the devices or engage directly with Quanta's full-service solutions for maintenance and replacements as needed.
These features offer IRC a competitive edge in streamlining patient care and minimizing delays. The Quanta system also provides a practical solution for environments with limited infrastructure, whether in hospitals or patient homes.
Reactions from Leadership
“Our teams are eager for this innovative option for our acute care patients,” expressed Sara Brady, the Chief Nursing Officer at IRC. “Having the ability to make real-time treatment adjustments on a single platform is truly transformative for our practice. We’re grateful for the partnership with Quanta and our collaboration with the MercyOne facility.”
Quanta's CEO, Alejandro Galindo, echoed her sentiments, stating, “We are thrilled to work alongside Innovative Renal Care to provide top-tier kidney care solutions. Our focus on acute care aims to illustrate that the Quanta system can thrive in demanding healthcare environments. This collaboration is paving the pathway for needed innovations that enhance patient care.”
About Quanta Dialysis Technologies
Quanta Dialysis Technologies dedicates its efforts to ensuring accessible, high-quality, and cost-effective dialysis solutions for all patients. The company has proudly received several accolades, including the prestigious MacRobert Award for engineering innovation. In recent years, the Quanta system gained FDA clearance for various modalities of dialysis, underscoring its commitment to advancing renal care technologies.
About Innovative Renal Care
Innovative Renal Care is lauded for its pioneering efforts in kidney care, collaborating closely with nephrologists and healthcare systems to deliver exemplary patient care. Their unique model of partnerships aims to provide tools, technology, and support to local care teams. With a focus on improving patient experiences and outcomes, IRC steadfastly maintains its commitment to advancing kidney care in a systematic and patient-first approach.
Frequently Asked Questions
What is the main goal of the Quanta and IRC partnership?
The goal is to broaden access to innovative dialysis solutions using the Quanta Dialysis System within IRC's programs.
What unique features does the Quanta Dialysis System offer?
It provides CRRT, SLED, and IHD capabilities on one machine, ensuring versatility and ease of use across various care settings.
Where was the pilot program for the Quanta system initiated?
The pilot program began at the MercyOne Waterloo Medical Center.
How has the Quanta system proven its effectiveness?
Over 130 treatments were performed during the pilot, demonstrating its adaptability and efficiency in treating critically ill patients.
What advantages does IRC gain from using the Quanta system?
IRC benefits from operational savings, enhanced patient care efficiencies, and the flexibility of training their own technicians for equipment management.
